Back to company

ELDON BIOLOGICALS A/S: Financial statements 2015

CVR: 26747007

ELDON BIOLOGICALS A/S (CVR 26747007) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 6,061,341 and a net result of DKK 1,501,774 compared with DKK 1,067,436 the year before. That is an increase of 23.7% compared with the year before. Equity amounted to DKK 318,935. The solvency ratio was 4.9%.

Gross Profit
6,061,341 kr.
Profit/Loss
1,501,774 kr.
Equity
318,935 kr.
Total Assets
6,455,327 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2015-6.1 mio.1.5 mio.319 t.-
2014-4.9 mio.1.1 mio.-1.2 mio.-
2013-4.1 mio.949 t.-2.3 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

About ELDON BIOLOGICALS A/S

ELDON BIOLOGICALS A/S is a Danish company of the type Aktieselskab based in Gentofte, founded in 2002. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The management consists of Kasper Juul Hedegaard. The company is owned by MEDI-TRADE ApS and HOLDINGSELSKABET MLH ApS. The company has 9 employees. In 2025, the company reported a gross profit of DKK 13,635,058 and a net result of DKK 3,900,353 compared with DKK 6,673,643 the year before. Equity amounted to DKK 42,055,949.